CEFADROXIL

Post-LOE

cefadroxil

Aurobindo Pharma

ANDAORALCAPSULE

Approved

Jan 2007

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

3/8 — Basic

Drug data last refreshed 20h ago

$0.0BPart D

Mechanism of Action

Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Clinical Trials (6)

NCT03802552Phase 1Completed

Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections

Started May 2019

17 enrolled

OsteomyelitisSeptic ArthritisPyomyositis

NCT02140281Phase 1Completed

To Assess the Effect of AZD1722 on the Pharmacokinetics of Cefadroxil in Healthy Volunteers

Started May 2014

71 enrolled

Healthy Volunteers

NCT02446496Phase 4Completed

A Bioequivalence Study of Cefadroxil Film Coated Tablets After A Single Oral Dose Administration to Healthy Subjects

Started Mar 2014

24 enrolled

Infections, Urinary Tract

NCT02479867Phase 1Completed

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Started Mar 2014

24 enrolled

Healthy

NCT00834275Phase 1Completed

Cefadroxil 500 mg Capsules Under Fasting Conditions

Started Sep 2004

26 enrolled

Healthy

Worked on CEFADROXIL at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.